Hopes build over Oxford & Moderna for Covid-19 vaccine
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Hopes for a working Covid-19 vaccine are growing as Teams from Oxford University and the American pharmaceutical company Moderna have reported promising results in their early experiments.

-- Oxford/AstraZeneca Vaccine (ChAdOx1 nCoV-19) --

• People being given the vaccine have been developing antibodies and T cells.

• Phase 3 trial is involving around 8,000 people across the UK and also up to 6,000 people in Brazil and South Africa.

• Type of recombinant viral vector vaccine, works by injecting a damaged part of the real coronavirus that has been attached to another, harmless, virus.

• Scientists are '80 per cent' confident that a jab could be ready by September

-- Moderna's Vaccine (mRNA-127) --

• Participants in their trial - of a different type of vaccine - all successfully developed antibodies.

• Researchers at the company last night announced that all 45 volunteers in its early phase had developed immune responses after being given the vaccine.

• It's now preparing to start a 30,000-person trial later this month.

• mRNA-1273 vaccine, works using ribonucleic acid (RNA), introduces RNA which programmes body to make proteins that look like those found on the surface of the coronavirus.

Source: https://www.dailymail.co.uk/news/article-8525393/Hopes-build-UK-Covid-vaccine-Oxford-drug-trials-work.html
A●●●●h A●●●●●l and 4 others like this1 share
Like
Comment
Share